Rituximab in Mucous Membrane Pemphigoid: Current Evidence and Clinical Perspectives. [PDF]
Popa LG +6 more
europepmc +1 more source
Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature. [PDF]
Filis P +7 more
europepmc +1 more source
Multidisciplinary wound care in an elderly patient with extensive bullous pemphigoid: a case report. [PDF]
Chen X, Mohammadnezhad M, Zhou Y, Qin Y.
europepmc +1 more source
Mucous membrane pemphigoid associated with thymoma: A rare cancer-associated immune manifestation. [PDF]
Fakih A, Makarem J, Sabbah N, Harb SB.
europepmc +1 more source
Combination biologic therapy in bullous pemphigoid: two case reports and a focused review. [PDF]
Kyriakou A +9 more
europepmc +1 more source
A Multicenter Analysis of Patients with Bullous Pemphigoid: Clinical Characteristics and Insights into Drug-Associated Disease. [PDF]
Małolepsza A +12 more
europepmc +1 more source
Mucosal Involvement in Bullous Pemphigoid: Severity Indicator and Associated Clinical Features from a Retrospective Cohort Study. [PDF]
Cui S +6 more
europepmc +1 more source
FcεRII (CD23) in dermatological disorders: structure, function, and clinical implications. [PDF]
Zdanowska N +4 more
europepmc +1 more source
A case of anti-laminin 332-type mucous membrane pemphigoid mimicking linear IgA bullous dermatosis. [PDF]
Du X, Dang J, Zhao J, Shang P.
europepmc +1 more source
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients. [PDF]
Pira A +28 more
europepmc +1 more source

